June 17, 2026

Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer

Roche: The new VENTANA® PTEN (SP218) RxDx Assay fulfills an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP. In prostate cancer, PTEN protein loss is associated...

recent articles

Another blogging pathologist -- welcome to Dr. Prashnant A. Jani from Thunder Bay, Ontario at Oncopathology. According to Dr. Jani, the purpose of the blog is to "post recent updates in Oncopathology as well as to evaluate the importance...

Here is a video from ABC News.  Certainly a debatable topic and add in "fee for service" by clinicians it may complicate the biology as well... http://abcnews.go.com/video/playerIndex?id=7053215...

Attended the USCAP meeting in Boston over the weekend.  On Saturday attended the DICOM Working Group 26 (WG 26) meeting.  A copy of the document discussed is available here. This was my first DICOM WG 26 meeting (as an observer) and...

There is an interesting interactive graphic here from the NY Times. County by county review since 1880 of immigrant population and total...

  Several items have been added to the Web 2.0 Expo SF agenda, including a Google keynote, brand new sessions, and the return of some favorite programs. Watch Twitter and the Web 2.0 Expo Blog for updates about our...

       The President has reversed a ban on federal funding for stem cell research, and it has received wide media coverage, with most reports -- including lead stories on two out of three network broadcasts...

OR

platinum partners

gold partners

Silver Partners

Media Partners